{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:51:55Z","timestamp":1781880715009,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Huangpu District Medical Key Specialty Discipline Construction Project Fund","award":["2023ZDZK01"],"award-info":[{"award-number":["2023ZDZK01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77117-y","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:02:40Z","timestamp":1729695760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic evaluation of segmental ureterectomy combined with chemotherapy in high-grade non-metastatic ureteral cancer: a study based on the SEER database"],"prefix":"10.1038","volume":"14","author":[{"given":"Yu","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Bin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"77117_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"77117_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupret","year":"2023","unstructured":"Roupret, M. et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur. Urol. 84, 49\u201364. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.013 (2023).","journal-title":"Eur. Urol."},{"key":"77117_CR3","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","volume":"70","author":"T Seisen","year":"2016","unstructured":"Seisen, T. et al. Oncologic outcomes of kidney-sparing surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a systematic review by the EAU non-muscle invasive bladder Cancer guidelines Panel. Eur. Urol. 70, 1052\u20131068. https:\/\/doi.org\/10.1016\/j.eururo.2016.07.014 (2016).","journal-title":"Eur. Urol."},{"key":"77117_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/bju.12631","volume":"114","author":"T Seisen","year":"2014","unstructured":"Seisen, T. et al. Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and\/or locally advanced upper tract urothelial carcinoma without metastasis. BJU Int. 114, 733\u2013740. https:\/\/doi.org\/10.1111\/bju.12631 (2014).","journal-title":"BJU Int."},{"key":"77117_CR5","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis, V. et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma collaboration. Cancer. 115, 1224\u20131233. https:\/\/doi.org\/10.1002\/cncr.24135 (2009).","journal-title":"Cancer"},{"key":"77117_CR6","unstructured":"Masson-Lecomte, A. et al. EAU Guidelines (EAU Guidelines Office, 2024)."},{"key":"77117_CR7","doi-asserted-by":"publisher","unstructured":"Paciotti, M. et al. Is Segmental Ureterectomy Associated with Inferior Survival for Localized Upper-Tract Urothelial Carcinoma of the ureter compared to Radical Nephroureterectomy? Cancers (Basel). 15https:\/\/doi.org\/10.3390\/cancers15051373 (2023).","DOI":"10.3390\/cancers15051373"},{"key":"77117_CR8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","volume":"395","author":"A Birtle","year":"2020","unstructured":"Birtle, A. et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. 395, 1268\u20131277. https:\/\/doi.org\/10.1016\/S0140-6736(20)30415-3 (2020).","journal-title":"Lancet"},{"key":"77117_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jfma.2013.04.001","volume":"113","author":"G Xiong","year":"2014","unstructured":"Xiong, G. et al. Prevalence and factors associated with baseline chronic kidney disease in China: a 10-year study of 785 upper urinary tract urothelial carcinoma patients. J. Formos. Med. Assoc. 113, 521\u2013526. https:\/\/doi.org\/10.1016\/j.jfma.2013.04.001 (2014).","journal-title":"J. Formos. Med. Assoc."},{"key":"77117_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","volume":"58","author":"MG Kaag","year":"2010","unstructured":"Kaag, M. G. et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur. Urol. 58, 581\u2013587. https:\/\/doi.org\/10.1016\/j.eururo.2010.06.029 (2010).","journal-title":"Eur. Urol."},{"key":"77117_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/cncr.30516","volume":"123","author":"P Zareba","year":"2017","unstructured":"Zareba, P., Rosenzweig, B., Winer, A. G. & Coleman, J. A. Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract. Cancer. 123, 1741\u20131750. https:\/\/doi.org\/10.1002\/cncr.30516 (2017).","journal-title":"Cancer"},{"key":"77117_CR12","doi-asserted-by":"publisher","unstructured":"Xylinas, E. et al. External validation of the pathological nodal staging score in upper tract urothelial carcinoma: a population-based study. Urol. Oncol. 35, 33 e21\u201333 e26. https:\/\/doi.org\/10.1016\/j.urolonc.2016.07.022 (2017).","DOI":"10.1016\/j.urolonc.2016.07.022"},{"key":"77117_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.juro.2011.10.158","volume":"187","author":"H Fajkovic","year":"2012","unstructured":"Fajkovic, H. et al. Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. J. Urol. 187, 845\u2013851. https:\/\/doi.org\/10.1016\/j.juro.2011.10.158 (2012).","journal-title":"J. Urol."},{"key":"77117_CR14","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.juro.2015.06.077","volume":"194","author":"SF Matin","year":"2015","unstructured":"Matin, S. F., Sfakianos, J. P., Espiritu, P. N., Coleman, J. A. & Spiess, P. E. Patterns of lymphatic metastases in Upper Tract Urothelial Carcinoma and proposed dissection templates. J. Urol. 194, 1567\u20131574. https:\/\/doi.org\/10.1016\/j.juro.2015.06.077 (2015).","journal-title":"J. Urol."},{"key":"77117_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupret","year":"2018","unstructured":"Roupret, M. et al. European Association of Urology Guidelines on Upper urinary tract Urothelial Carcinoma: 2017 update. Eur. Urol. 73, 111\u2013122. https:\/\/doi.org\/10.1016\/j.eururo.2017.07.036 (2018).","journal-title":"Eur. Urol."},{"key":"77117_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.euf.2017.09.015","volume":"5","author":"JL Dominguez-Escrig","year":"2019","unstructured":"Dominguez-Escrig, J. L. et al. Potential benefit of Lymph Node Dissection during Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a systematic review by the European Association of Urology Guidelines Panel on non-muscle-invasive bladder Cancer. Eur. Urol. Focus. 5, 224\u2013241. https:\/\/doi.org\/10.1016\/j.euf.2017.09.015 (2019).","journal-title":"Eur. Urol. Focus"},{"key":"77117_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11255-022-03429-5","volume":"55","author":"Y Qiu","year":"2023","unstructured":"Qiu, Y. et al. Comparable survival benefits of partial ureterectomy to radical nephroureterectomy in non-metastatic ureter carcinoma: a population-matched study. Int. Urol. Nephrol. 55, 579\u2013588. https:\/\/doi.org\/10.1007\/s11255-022-03429-5 (2023).","journal-title":"Int. Urol. Nephrol."},{"key":"77117_CR18","doi-asserted-by":"publisher","unstructured":"Slusarczyk, A. et al. Oncologic outcomes of patients treated with kidney-sparing surgery or radical nephroureterectomy for upper urinary tract urothelial cancer: a population-based study. Urol. Oncol. 42 (22 e21-22 e11). https:\/\/doi.org\/10.1016\/j.urolonc.2023.09.019 (2024).","DOI":"10.1016\/j.urolonc.2023.09.019"},{"key":"77117_CR19","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1007\/s00345-021-03776-5","volume":"39","author":"F Claps","year":"2021","unstructured":"Claps, F. et al. Risk factors associated with positive surgical margins\u2019 location at radical cystectomy and their impact on bladder cancer survival. World J. Urol. 39, 4363\u20134371. https:\/\/doi.org\/10.1007\/s00345-021-03776-5 (2021).","journal-title":"World J. Urol."},{"key":"77117_CR20","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.3390\/jcm13154349","volume":"13","author":"F Claps","year":"2024","unstructured":"Claps, F. et al. The Prognostic significance of histological subtypes in patients with muscle-invasive bladder Cancer: an overview of the current literature. J. Clin. Med. 13, 4349. https:\/\/doi.org\/10.3390\/jcm13154349 (2024).","journal-title":"J. Clin. Med."},{"key":"77117_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrurol.2017.125","volume":"14","author":"M Moschini","year":"2017","unstructured":"Moschini, M. et al. Characteristics and clinical significance of histological variants of bladder cancer. Nat. Rev. Urol. 14, 651\u2013668. https:\/\/doi.org\/10.1038\/nrurol.2017.125 (2017).","journal-title":"Nat. Rev. Urol."},{"key":"77117_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.clgc.2023.05.011","volume":"21","author":"A Douglawi","year":"2023","unstructured":"Douglawi, A. et al. Impact of variant histology on oncological outcomes in Upper Tract Urothelial Carcinoma: results from the ROBUUST Collaborative Group. Clin. Genitourin. Cancer. 21, 563\u2013568. https:\/\/doi.org\/10.1016\/j.clgc.2023.05.011 (2023).","journal-title":"Clin. Genitourin. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77117-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:07:37Z","timestamp":1729696057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77117-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77117"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77117-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"8 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25090"}}